{"ticker": {"uuid": "31c24033-052d-410b-86ba-a577747db270", "symbol": "RCE", "name": "Recce Pharmaceuticals Ltd", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Recce Pharmaceuticals (ASX: RCE) Advances Clinical Pipeline in the Fight Against Antibiotic Resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPd1FaRGRVRE5Bb29zeFROakduMjFDUmxxOUh1UGkxSHRKbEFUakwwRjVwemM1YVBydzVmRnlkWElEQ0d0bUNTYlpJZzZmVWNVVWtFMll3ckZ0SG1FakpBUkxBU1o5RFZRT0E0SDdTdURuR1F4dkhsR1hsOTVMY3lheWVIWVFrMmVHMnJzQy1zalBnYVllWFoxa2htWWJYNS1iTjM4YWd0MnJMVnp0bDAyakFWa0Z0R3VxM2ZXZXV5czc1cEpIMHdLRVRFMlZjQlQzNUs4S3hB?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T07:18:00+00:00", "published_display": "17 Jul 2026 07:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Healthcare Stocks: Why Is Recce Pharmaceuticals (ASX:RCE) in Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQMGFqelUxOGxGWUR0Z3JFMTlGSVZUX2MxVFRXNlZXY1NvRlp0VzZHTTFzdHU5dnNLYlB5QWxPMVpYVFduakJ4TDNLbzNEWDgxZFNoRHJjLWlnX3Bxc3R5MUtHUzNNVkpUc3BKd1pIaHVTelAwUTVtMldRVnRVaG5wU01DUGxhWEVaeVllYm9EUVpSM044STh1UGtheGxSSmU3REE5T25sOTJOMmhpbW9QeGFB?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-17T03:36:00+00:00", "published_display": "17 Jul 2026 03:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Today: Why Recce Pharmaceuticals (ASX:RCE) Shares Are Gaining", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeTB6TXdTTE90eXV4S3lGRmthOE51NVRVVzRmLVVId2RmY044NklOSUFPcXI1eGVHRkhQanR0d1NhTXFLQkE0eTI1cl95bG9sMUlMVFp5bXJNU3c1bVFkelI5SlRDRjJkeV81VV90eHVKVmRnNXM4cHdMWkxqcGhDVUFydnpqdTVVZXY1LTRHVkxxeHl6b2I4QUIzRWhUVUcxYlE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-16T07:11:00+00:00", "published_display": "16 Jul 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes (ASX:RCE) a Healthcare Pipeline Signal?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQcGhuall3bWdOR1B5VGw5eTVnWFprYkNEbHNjWktVNTFmcnN6UXZlalNjbHRhS2JDajItMkRUZ09EU19WSW15MGxmZHVaRkNVZG9tMUpSbTYyeC1XY2kzTUhKWmstN1V4Xy1DRmd0M05jTWY2T0VOZThLbzNnb1JGZjcybmpEOTh0TjlfS1A4TG50VER2bTUw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-15T04:30:00+00:00", "published_display": "15 Jul 2026 04:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals (ASX:RCE) Expands Global Patent Footprint for Its Anti-Infective Drug Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQckVXd0VUQXlGZEdaNGJTTG9iYjhteTFFaE1hSk5xek5CdmdhYnMtYm5Fa3gxNm9BVzRTLXpPTHJibzA0QzBGTEE1amNDUGROU28tZktoZnJJWllIeEoxMjM0TUM3SVNRVnY1N2RidXpMTFFqaUE0UVZLSkQ2a29GNDBVMG9Bd09LUjYzeUhqR04waGdFRTRadnh0TTZHenRMc245MUh3NFhVdUV1OFNVV2NKQ3JTWTlERll2aW9Nc0J1d3doOVdZRm5mYWh4N0VtcXc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T10:44:00+00:00", "published_display": "14 Jul 2026 10:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recce Pharmaceuticals (ASX:RCE) Is Expanding Its ASEAN Footprint", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQam5GOWJXQ3NVTU1aLVEyUFRLT1BzNWhEdWY2V0tIYXAzMGxsdnpfVDhNZVBxVmctc1pfaWxDc1NOaXp1ZmNOQXU5T2dkYW8yczdFMDZuTEJtRHM3VlZqTk9nMHZpOTF3WW1yMmtvODg5ejF4QktiMHMydXJnc0JwM0pDQmRieGVmVmQyMXhhb3VlTl9hQWRubFJId0lSYXdFdGZmV29jTHhVa0wwVnRJaw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-14T05:05:00+00:00", "published_display": "14 Jul 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Secures Family 4 Patent for Anti-Infectives in Vietnam", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbHNMYnh5dWM2dl9CaW9OTTdnanYtT2hxRnFibWJMaHp4QnJpOEthUXZmM3llZ1NaQVltbHRLcUlrazhlR2FUWGlTTFU2aWthQS12M0R4bzFaVlJBVU16NFdpSU5HekJieFZjYnJubEZwcmVyOHpIOVVBRHRrOGZ2TF9SR0hPbDMyUS1ZUW83OVBCcHNiOGFHcklUVGlkQTRDemtDTkxaMDE4VmxISU1nbTlfS3NyMXBaSWM0UEtsV2p3QW9qRTI5SlN4bTRfaEJBb3pIeWl4cjV2ajBwd1E?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T01:05:14+00:00", "published_display": "14 Jul 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Recce Pharmaceuticals Ltd. \u2013 ASX:RCE", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOQmNtWkt2T1F3OXdsU3ZWT1QyakxpU1ZzVmNSMHZXTW5pZ0hQd0dfV0NrUW1renFzai02M0FuVkRZaHVKdndkREQ1Sk1GM0xpRExkSno0cDZpdnBHNXdBVGZ2QVgzYVlhWXJYSEM0cmdMRWlCaGEzZVpMNkhSTVlvbmJrTjlsYVJaM0hRQU9Zb3NiOGhONjZyVWk3Nzk?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T13:53:50+00:00", "published_display": "05 Jul 2026 13:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Ltd (ASX:RCE) Enters Trading Pause Pending a Further Announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUHdWQXYtbEQzU3JmWjM0ZnB1ZFJDbzhUTXE1Q3czVWlfbGdLM0o1VUdQTE40Mzlwb1cyTWpndDRDYzFMQlVnWDlJSWlYSXpkNzhGUHpKazdpekpWWmFNNlRTY2twR2RINE1vd0VOYXpQeV9LZ0lmTTlXYVNqTS0zRElCRDdaN3hqUzEyM2VWRVpqMm9QbEh6RkVCR3JPZWpXQ3NONjlVV3lHY3dRbFU0N3pyWjJpR05melIyWDR3QVU?oc=5", "source_name": "Kalkine", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Requests Trading Halt Ahead of Equity Raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOb2UyWUcyaU44WXhKNG5TTGNiTk94cklnNWVCbnNNSEtCQlVTOFJjSTZEVklpU1MxaFgyMnFxa3prLUNQNlY1dDJWVzRoaWNqM081dDlLbVlLenAxX2ZRcXZsa2dpUnVVV3J2Sy02UDVkUGRuSTFaYm5GdjVBN19IdFBFQnNfdm1Nc1dSLUY4WWlYR2x6RDJzUktQRTd3Y3RlNkFVNTlQenByaXM?oc=5", "source_name": "Moomoo", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A AU$23m Market Cap Boost Pleasing ToRecce Pharmaceuticals Insiders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPQ1VObGJacmNBX1RESkxWUzNHc0I5dXc5NnZfRU8yVkN5bU5UNWNJQ00wdF9vVXFYZHBLb242TzYwUFlLc0tHYVN4QWxiekZDamktcG1ISXVIVVRSaTU4eTdDaTMtYzh3UVRhSjkyN2tkTHBZQ2lBTmdTWF9OYlVFWktRN1RKSXZ5RlRRYXV1RXZzQVVzemdmZFpINnFlMkROSXZxeFQ3c243VHVFUUdaY0J5cUQzRDlJVUwxRWtxRUgyUExGY3RYaGt5UnNvbXpBQmFvM19mZHVXZlNkYzlmYmt6ZnI0SnRPZUpRZ3R5d9IB9AFBVV95cUxQTWRwRm4zM0F6VWZyMDNRWUNXMUtxbEVpb2I0bkZhRmlfMHB5VmxTbU52YmxULW5aNDRiU2NDNzJXTjR2VTdBOFhoQjNKWFA5c2JzQURsNGJMcG9odFB2Mzc0dWYtakJQWm92bHhLeC1kU3VLSG0tc1ZaSmlLNFRyM0c5YXlDYngtdjdFRWY4VkZjbHQ3OUFDSEtNTV84RlNaUmdncGo1OXZ6ZW5DTkU0Qy1RZEw4YlpyUzJmajhVcU1qQWlJeGtzRzE2cGJ2OWRqNHZYenppSzZ4aHFTdFNhY2ZtYkpBX1lvS0NvV0VVT1NOV1pH?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "56% in a Year and Still Climbing \u2014 What\u2019s Driving Recce Pharmaceuticals' (ASX:RCE) Momentum?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOSm40OFZWaWRDS01XYmp5c1RKVkJUQ0kzTmxsZHRDV3llX3FxWW10R1pNUEJMMlFqbnBTXzg4UXlwbEo4Y3MtOHc3SkJqZEhvcUt0aGN2TzY1X0tuUFlDaVZHRHVWcHFlN2ZZRVRzUGJhVFBTMXc0bkVjN1FYckhhQWM1NUlCb1oxNUZuZmtpc0ExcHBFdG1FQTJjQkVFTzNwOUdpMkhWSjB6U0hpNWwtd0p1OWhFNEdlMS1WYklmdw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "No more tears as Recce takes on antibiotic superbug crisis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQ0E2VjZ1aS16am5oYUhYNmE5X2JIT3F6U0NQS180OHV6NWxmMVJTOUdvcjF6RzZOSWdLNEluM2huaTNIemZLeTdzRWZoZFhrZ000RGtydUFmVmtZX1JSbDJVSWNqQmtlNVFmckNGeFpndnpkT2U4ZGhCR3lxUjlBSnk5aEFrSXVxeDVObHFRU0tPWldzMFE?oc=5", "source_name": "Stockhead", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz: Recce Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwJBVV95cUxPT2tzSzM0MjFBVENOQ3FnLW9QRzk1Ulo5WFA2Tk5mUk5pdEpYeDhIY2tUVGxuVmZFZ1FhS1o2M1dNTWJqLXR3SVRhX01NNWgzTUpJMG52Uy16TnlCbXNyT0xXcklvWks2X2YzTGp6dFFCM3M5dzJJUEdWM1pKWkhoVVkwVi04bkEzVGhIVE9jb2RnaDM0MkFsUmVybkp0UDlyOGtSbmUxamkxckxOYWxVdXppZ3pVbVNyWkFCdUNaY0YwWjRZNjh1cTFDcThLLV9EVXdxRlFZbWp5MkQyMGF6ckpxR1M0TXhKa2J4UmFabGppR01QcmZ2Y3l5R2QyQWZHVHQzZldLTGw1T1EyZFZF0gGUAkFVX3lxTE9WRVNPbnJ4YW1fRE9sQXBqcUJYQmtUZUw3VUNBbUdOc0NCRTNia1g0dVFIZThReVUzc2J0bFlWa2lQVDJPRzYzNTR5RFE1WHFWb3Jqd0lOLVJERGlPTUQ4Qm9fdi1ZTFM0NXBHcFgtcThQTXRWUl9HMl9obzZxamROQzhhM3NvNkNqaGVKcV9OYUF2SzJpVUdsUmtXNTQ0VTdtS2p0UnV3T2pLR2VwOHU0NmVuUVlOcVFvcmhxb0VJZ0g2Tmx1bjRmZTNkaUVEcFVIZGtzN09DRkg0QUZpZG9kY1RiZjVJaWdHaTBFZDZ0U3NZbGxTRUo3MEE3R1BMQ1FFU0w4RlppUnJ4RkhaOExlWFg1Qw?oc=5", "source_name": "The Australian", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals (ASX:RCE) Stock Is in Focus: Phase 3 Trial Progress and the Fight Against Antibiotic Resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPaFBVWExWQ1JqTlF6c3o0ZmhHaXQ4ZzhMV3hneTlFLWF4UTAtbTVrQ1FRdWI0bG01QVRveEtPRnZwQXczMzRJT0hfM211STk5N1ZxdHlaU1FjQUdpQmZDOGZmQUhzV0FvZ3VrallhTHpoQUhQYnNhQkVCeFVOejJWdlk3ZUk1LVhGQnZMOXFNVWwwSENpZlFXZ3h4UmdJS29qUXV3dUpKV29ZZjgwNHc2SnRCWlNleC1IcmUyVkFNQmVxMlpjdmNMaVpBSVllT0pxX0d3YjFnZDJybGRRUHRYTm5KVXBRSFU?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recce Pharmaceuticals Stock Is Surging Today: Key Catalysts Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOT2FsTDdkSVFvV2dfOGViTy1ZQkl3WDFIdHRxOGFnYm9US0JObE1kcThnSjRPNllyNE9RWE9GLUd4aHhLQjFKUkF1WjF4TmtpS0lKLVpHXzFPaWJadFhxVFF0czJqdWRYbjQ0VE83eDN3ZHljUlZUTEpLcVUtWjRKZF9pR1ZhemJRN0tSYVBKRVRhR1VXU21GZXlfVi1mMnUweTFCdmpkcnFuM3d1N0otVDcxN0JsRm5pV1JLeG5CMjY?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All Ordinaries Healthcare Focus as Recce Signs US Army CRADA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTHRWUi1ZTlZMYlFtWlNuUDNuekRJTjdod0N5cTg4dHhHR1ZLMHJ2dHZfMkNTMHdNTVFmUXNxRm1tdWhQZTZBX1gtbC1ySkZQbW9tdGtLT0xUUE1KUERJRmsxREJCMldCcjZrcFhYS2tLSE1NMUs5LW9jaDlHRjAxQ1hFU0h5d0lVa01IaGVZVGtwajJnSk1fTWhwNkZSSlhZRXRMN0IwbVZwUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Retail investors invested in Recce Pharmaceuticals Ltd (ASX:RCE) copped the brunt of last week's AU$29m market cap decline", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Recce Pharmaceuticals Ltd (ASX:RCE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBiVG5JdUZnYkNKYnZTSUpRNlNGVVhZa2RBamE0YmNQN0JMRXgzUDQxSXVWaWZkLXZaMmlTSFNnaG9ZNnBiRXZ1d3NKZng4c0hJ?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T23:51:50+00:00", "published_display": "30 Oct 2025 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce targets A$15.8M to advance anti-infectives into Phase 3 trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOY1UxUWU5NjF0aFRCdEZXUkdxT0wzVkxWZkFCQWdFREVabGo5RWJCSDlwOGtyU0RJQUN0QmNvckJncmxuN2FCcVM3ZXRmYlhfUVAyQUxXX3ZrcTFnRDc2VUFXXzVncURKdnJRVmFnbmpGbWdZanZsUlY3dXJja2x6U1Z6THNCLXYxckpLUmVTRWVqVS01aVc2ZUp5OU9ZRnFiX2ZHSTV5OA?oc=5", "source_name": "drugdiscoverytrends.com", "published_at": "2025-04-10T07:00:00+00:00", "published_display": "10 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Recce Pharmaceuticals (ASX: RCE) Advances Clinical Pipeline in the Fight Against Antibiotic Resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPd1FaRGRVRE5Bb29zeFROakduMjFDUmxxOUh1UGkxSHRKbEFUakwwRjVwemM1YVBydzVmRnlkWElEQ0d0bUNTYlpJZzZmVWNVVWtFMll3ckZ0SG1FakpBUkxBU1o5RFZRT0E0SDdTdURuR1F4dkhsR1hsOTVMY3lheWVIWVFrMmVHMnJzQy1zalBnYVllWFoxa2htWWJYNS1iTjM4YWd0MnJMVnp0bDAyakFWa0Z0R3VxM2ZXZXV5czc1cEpIMHdLRVRFMlZjQlQzNUs4S3hB?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T07:18:00+00:00", "published_display": "17 Jul 2026 07:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Healthcare Stocks: Why Is Recce Pharmaceuticals (ASX:RCE) in Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQMGFqelUxOGxGWUR0Z3JFMTlGSVZUX2MxVFRXNlZXY1NvRlp0VzZHTTFzdHU5dnNLYlB5QWxPMVpYVFduakJ4TDNLbzNEWDgxZFNoRHJjLWlnX3Bxc3R5MUtHUzNNVkpUc3BKd1pIaHVTelAwUTVtMldRVnRVaG5wU01DUGxhWEVaeVllYm9EUVpSM044STh1UGtheGxSSmU3REE5T25sOTJOMmhpbW9QeGFB?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-17T03:36:00+00:00", "published_display": "17 Jul 2026 03:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Today: Why Recce Pharmaceuticals (ASX:RCE) Shares Are Gaining", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeTB6TXdTTE90eXV4S3lGRmthOE51NVRVVzRmLVVId2RmY044NklOSUFPcXI1eGVHRkhQanR0d1NhTXFLQkE0eTI1cl95bG9sMUlMVFp5bXJNU3c1bVFkelI5SlRDRjJkeV81VV90eHVKVmRnNXM4cHdMWkxqcGhDVUFydnpqdTVVZXY1LTRHVkxxeHl6b2I4QUIzRWhUVUcxYlE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-16T07:11:00+00:00", "published_display": "16 Jul 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes (ASX:RCE) a Healthcare Pipeline Signal?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQcGhuall3bWdOR1B5VGw5eTVnWFprYkNEbHNjWktVNTFmcnN6UXZlalNjbHRhS2JDajItMkRUZ09EU19WSW15MGxmZHVaRkNVZG9tMUpSbTYyeC1XY2kzTUhKWmstN1V4Xy1DRmd0M05jTWY2T0VOZThLbzNnb1JGZjcybmpEOTh0TjlfS1A4TG50VER2bTUw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-15T04:30:00+00:00", "published_display": "15 Jul 2026 04:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals (ASX:RCE) Expands Global Patent Footprint for Its Anti-Infective Drug Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQckVXd0VUQXlGZEdaNGJTTG9iYjhteTFFaE1hSk5xek5CdmdhYnMtYm5Fa3gxNm9BVzRTLXpPTHJibzA0QzBGTEE1amNDUGROU28tZktoZnJJWllIeEoxMjM0TUM3SVNRVnY1N2RidXpMTFFqaUE0UVZLSkQ2a29GNDBVMG9Bd09LUjYzeUhqR04waGdFRTRadnh0TTZHenRMc245MUh3NFhVdUV1OFNVV2NKQ3JTWTlERll2aW9Nc0J1d3doOVdZRm5mYWh4N0VtcXc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T10:44:00+00:00", "published_display": "14 Jul 2026 10:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recce Pharmaceuticals (ASX:RCE) Is Expanding Its ASEAN Footprint", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQam5GOWJXQ3NVTU1aLVEyUFRLT1BzNWhEdWY2V0tIYXAzMGxsdnpfVDhNZVBxVmctc1pfaWxDc1NOaXp1ZmNOQXU5T2dkYW8yczdFMDZuTEJtRHM3VlZqTk9nMHZpOTF3WW1yMmtvODg5ejF4QktiMHMydXJnc0JwM0pDQmRieGVmVmQyMXhhb3VlTl9hQWRubFJId0lSYXdFdGZmV29jTHhVa0wwVnRJaw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-14T05:05:00+00:00", "published_display": "14 Jul 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Secures Family 4 Patent for Anti-Infectives in Vietnam", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbHNMYnh5dWM2dl9CaW9OTTdnanYtT2hxRnFibWJMaHp4QnJpOEthUXZmM3llZ1NaQVltbHRLcUlrazhlR2FUWGlTTFU2aWthQS12M0R4bzFaVlJBVU16NFdpSU5HekJieFZjYnJubEZwcmVyOHpIOVVBRHRrOGZ2TF9SR0hPbDMyUS1ZUW83OVBCcHNiOGFHcklUVGlkQTRDemtDTkxaMDE4VmxISU1nbTlfS3NyMXBaSWM0UEtsV2p3QW9qRTI5SlN4bTRfaEJBb3pIeWl4cjV2ajBwd1E?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T01:05:14+00:00", "published_display": "14 Jul 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Recce Pharmaceuticals Ltd. \u2013 ASX:RCE", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOQmNtWkt2T1F3OXdsU3ZWT1QyakxpU1ZzVmNSMHZXTW5pZ0hQd0dfV0NrUW1renFzai02M0FuVkRZaHVKdndkREQ1Sk1GM0xpRExkSno0cDZpdnBHNXdBVGZ2QVgzYVlhWXJYSEM0cmdMRWlCaGEzZVpMNkhSTVlvbmJrTjlsYVJaM0hRQU9Zb3NiOGhONjZyVWk3Nzk?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T13:53:50+00:00", "published_display": "05 Jul 2026 13:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Ltd (ASX:RCE) Enters Trading Pause Pending a Further Announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUHdWQXYtbEQzU3JmWjM0ZnB1ZFJDbzhUTXE1Q3czVWlfbGdLM0o1VUdQTE40Mzlwb1cyTWpndDRDYzFMQlVnWDlJSWlYSXpkNzhGUHpKazdpekpWWmFNNlRTY2twR2RINE1vd0VOYXpQeV9LZ0lmTTlXYVNqTS0zRElCRDdaN3hqUzEyM2VWRVpqMm9QbEh6RkVCR3JPZWpXQ3NONjlVV3lHY3dRbFU0N3pyWjJpR05melIyWDR3QVU?oc=5", "source_name": "Kalkine", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals Requests Trading Halt Ahead of Equity Raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOb2UyWUcyaU44WXhKNG5TTGNiTk94cklnNWVCbnNNSEtCQlVTOFJjSTZEVklpU1MxaFgyMnFxa3prLUNQNlY1dDJWVzRoaWNqM081dDlLbVlLenAxX2ZRcXZsa2dpUnVVV3J2Sy02UDVkUGRuSTFaYm5GdjVBN19IdFBFQnNfdm1Nc1dSLUY4WWlYR2x6RDJzUktQRTd3Y3RlNkFVNTlQenByaXM?oc=5", "source_name": "Moomoo", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A AU$23m Market Cap Boost Pleasing ToRecce Pharmaceuticals Insiders", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "56% in a Year and Still Climbing \u2014 What\u2019s Driving Recce Pharmaceuticals' (ASX:RCE) Momentum?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOSm40OFZWaWRDS01XYmp5c1RKVkJUQ0kzTmxsZHRDV3llX3FxWW10R1pNUEJMMlFqbnBTXzg4UXlwbEo4Y3MtOHc3SkJqZEhvcUt0aGN2TzY1X0tuUFlDaVZHRHVWcHFlN2ZZRVRzUGJhVFBTMXc0bkVjN1FYckhhQWM1NUlCb1oxNUZuZmtpc0ExcHBFdG1FQTJjQkVFTzNwOUdpMkhWSjB6U0hpNWwtd0p1OWhFNEdlMS1WYklmdw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "No more tears as Recce takes on antibiotic superbug crisis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQ0E2VjZ1aS16am5oYUhYNmE5X2JIT3F6U0NQS180OHV6NWxmMVJTOUdvcjF6RzZOSWdLNEluM2huaTNIemZLeTdzRWZoZFhrZ000RGtydUFmVmtZX1JSbDJVSWNqQmtlNVFmckNGeFpndnpkT2U4ZGhCR3lxUjlBSnk5aEFrSXVxeDVObHFRU0tPWldzMFE?oc=5", "source_name": "Stockhead", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz: Recce Pharmaceuticals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce Pharmaceuticals (ASX:RCE) Stock Is in Focus: Phase 3 Trial Progress and the Fight Against Antibiotic Resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPaFBVWExWQ1JqTlF6c3o0ZmhHaXQ4ZzhMV3hneTlFLWF4UTAtbTVrQ1FRdWI0bG01QVRveEtPRnZwQXczMzRJT0hfM211STk5N1ZxdHlaU1FjQUdpQmZDOGZmQUhzV0FvZ3VrallhTHpoQUhQYnNhQkVCeFVOejJWdlk3ZUk1LVhGQnZMOXFNVWwwSENpZlFXZ3h4UmdJS29qUXV3dUpKV29ZZjgwNHc2SnRCWlNleC1IcmUyVkFNQmVxMlpjdmNMaVpBSVllT0pxX0d3YjFnZDJybGRRUHRYTm5KVXBRSFU?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recce Pharmaceuticals Stock Is Surging Today: Key Catalysts Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOT2FsTDdkSVFvV2dfOGViTy1ZQkl3WDFIdHRxOGFnYm9US0JObE1kcThnSjRPNllyNE9RWE9GLUd4aHhLQjFKUkF1WjF4TmtpS0lKLVpHXzFPaWJadFhxVFF0czJqdWRYbjQ0VE83eDN3ZHljUlZUTEpLcVUtWjRKZF9pR1ZhemJRN0tSYVBKRVRhR1VXU21GZXlfVi1mMnUweTFCdmpkcnFuM3d1N0otVDcxN0JsRm5pV1JLeG5CMjY?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All Ordinaries Healthcare Focus as Recce Signs US Army CRADA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTHRWUi1ZTlZMYlFtWlNuUDNuekRJTjdod0N5cTg4dHhHR1ZLMHJ2dHZfMkNTMHdNTVFmUXNxRm1tdWhQZTZBX1gtbC1ySkZQbW9tdGtLT0xUUE1KUERJRmsxREJCMldCcjZrcFhYS2tLSE1NMUs5LW9jaDlHRjAxQ1hFU0h5d0lVa01IaGVZVGtwajJnSk1fTWhwNkZSSlhZRXRMN0IwbVZwUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Retail investors invested in Recce Pharmaceuticals Ltd (ASX:RCE) copped the brunt of last week's AU$29m market cap decline", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Recce Pharmaceuticals Ltd (ASX:RCE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBiVG5JdUZnYkNKYnZTSUpRNlNGVVhZa2RBamE0YmNQN0JMRXgzUDQxSXVWaWZkLXZaMmlTSFNnaG9ZNnBiRXZ1d3NKZng4c0hJ?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T23:51:50+00:00", "published_display": "30 Oct 2025 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recce targets A$15.8M to advance anti-infectives into Phase 3 trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOY1UxUWU5NjF0aFRCdEZXUkdxT0wzVkxWZkFCQWdFREVabGo5RWJCSDlwOGtyU0RJQUN0QmNvckJncmxuN2FCcVM3ZXRmYlhfUVAyQUxXX3ZrcTFnRDc2VUFXXzVncURKdnJRVmFnbmpGbWdZanZsUlY3dXJja2x6U1Z6THNCLXYxckpLUmVTRWVqVS01aVc2ZUp5OU9ZRnFiX2ZHSTV5OA?oc=5", "source_name": "drugdiscoverytrends.com", "published_at": "2025-04-10T07:00:00+00:00", "published_display": "10 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 20, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 17, "score": 51, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 93, "events": [{"event": "general", "label": "Market update", "weight": 10.45, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.39, "latest_week": "2026-07-10", "one_week_move": 2.7, "four_week_move": -23.0, "twelve_week_move": -32.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.486981, "market_dynamics_buy_signal": false, "relative_strength": -21.285312, "fair_value_gap": -19.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.6757, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.7% over one week, -23.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 7}, {"label": "Kalkine Media", "count": 4}, {"label": "Moomoo", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Stockhead", "count": 1}, {"label": "The Australian", "count": 1}, {"label": "smallcaps.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "93/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.7% over one week, -23.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Recce Pharmaceuticals (ASX: RCE) Advances Clinical Pipeline in the Fight Against Antibiotic Resistance"}], "updated_at": "2026-07-17T09:39:38.768975+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}